These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1311892)

  • 1. The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children.
    Loche S; Pintus S; Carta D; Muntoni AC; Congiu G; Civolani P; Pintor C
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):124-7. PubMed ID: 1311892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children.
    Loche S; Pintor C; Cappa M; Ghigo E; Puggioni R; Locatelli V; Müller EE
    Acta Endocrinol (Copenh); 1989 May; 120(5):624-8. PubMed ID: 2499149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children.
    Loche S; Pintus S; Cella SG; Boghen M; Vannelli S; Benso L; Müller EE; Corda R; Pintor C
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):187-92. PubMed ID: 1699689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of beta 1-adrenergic blockade on the growth response to growth hormone (GH)-releasing hormone therapy in GH-deficient children.
    Cassorla F; Mericq V; García H; Cristiano A; Avila A; Boric A; Iñiguez G; Merriam GR
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2997-3001. PubMed ID: 7559887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol enhances nocturnal growth hormone (GH) release in GH-deficient children during long term GH-releasing hormone therapy.
    Martha PM; Blizzard RM; Thorner MO; Rogol AD
    J Clin Endocrinol Metab; 1990 Jan; 70(1):56-61. PubMed ID: 2104629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone response to growth hormone-releasing hormone (GHRH), insulin, clonidine and arginine after GHRH pretreatment in obese children: evidence of somatostatin increase?
    Volta C; Bernasconi S; Iughetti L; Ghizzoni L; Rossi M; Costa M; Cozzini A
    Eur J Endocrinol; 1995 Jun; 132(6):716-21. PubMed ID: 7788012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children.
    Ghigo E; Mazza E; Corrias A; Imperiale E; Goffi S; Arvat E; Bellone J; De Sanctis C; Müller EE; Camanni F
    Metabolism; 1989 Jul; 38(7):631-3. PubMed ID: 2500577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
    Giustina A; Bresciani E; Tassi C; Girelli A; Valentini U
    Metabolism; 1994 Jul; 43(7):893-8. PubMed ID: 8028515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects.
    Castro RC; Vieira JG; Chacra AR; Besser GM; Grossman AB; Lengyel AM
    Acta Endocrinol (Copenh); 1990 Mar; 122(3):385-90. PubMed ID: 2109445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.